PlainRecalls
FDA Devices Low Class III Terminated

Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay in vitro diagnostic system for use on the Illumina MiSeqDx Platform.

Reported: December 31, 2014 Initiated: November 6, 2014 #Z-0850-2015

Product Description

Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay in vitro diagnostic system for use on the Illumina MiSeqDx Platform.

Reason for Recall

Illumina has confirmed a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay on the MiSeqDx instrument.

Details

Recalling Firm
Illumina Inc
Units Affected
19 units
Distribution
US: MD, NY Non-US: France
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay in vitro diagnostic system for use on the Illumina MiSeqDx Platform.. Recalled by Illumina Inc. Units affected: 19 units.
Why was this product recalled?
Illumina has confirmed a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay on the MiSeqDx instrument.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 31, 2014. Severity: Low. Recall number: Z-0850-2015.